Cargando…
Procalcitonin-guided diagnosis and antibiotic stewardship revisited
Several controlled clinical studies have evaluated the potential of the infection biomarker procalcitonin (PCT) to improve the diagnostic work-up of patients with bacterial infections and its influence on decisions regarding antibiotic therapy. Most research has focused on lower respiratory tract in...
Autores principales: | Sager, Ramon, Kutz, Alexander, Mueller, Beat, Schuetz, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259962/ https://www.ncbi.nlm.nih.gov/pubmed/28114931 http://dx.doi.org/10.1186/s12916-017-0795-7 |
Ejemplares similares
-
Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future
por: Schuetz, Philipp, et al.
Publicado: (2011) -
When once is not enough – further evidence of procalcitonin-guided antibiotic stewardship
por: Harbarth, Stephan, et al.
Publicado: (2009) -
Procalcitonin-guided antibiotic therapy in patients with congestive heart failure and suspicion of lower respiratory tract infection: results from a randomized trial
por: Schuetz, P, et al.
Publicado: (2013) -
Infection biomarkers in primary care patients with acute respiratory tract infections–comparison of Procalcitonin and C-reactive protein
por: Meili, Marc, et al.
Publicado: (2016) -
Prognostic value of procalcitonin in respiratory tract infections across clinical settings
por: Kutz, A, et al.
Publicado: (2015)